Age as a determinant of survival in HIV infection

Journal of Clinical Epidemiology

Volumn 54, Issue 12 SUPPL. 1, 2001, Pages

  Babiker, A G ^a   Peto, T ^a   Porter, K ^a   Walker, A S ^a   Darbyshire, J H ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Age; HAART; HIV infection; Mortality; Seroconversion

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADJUSTMENT; ADULT; AGE; AGED; CELL COUNT; CONFERENCE PAPER; DISEASE COURSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATHOPHYSIOLOGY; PATIENT CODING; PRIORITY JOURNAL; SEROCONVERSION; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGE FACTORS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHRONIC DISEASE; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; SURVIVAL ANALYSIS; TIME FACTORS; UNITED STATES;

EID: 0035658955     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(01)00456-5     Document Type: Conference Paper

References (11)

1. Time from HIV-1 seroconversion to AIDS and death before the widespread use of highly active antiretroviral therapy; a collaborative re-analysis
2. Models for the incubation of AIDS and variates according to age and period
3. Long-term HIV-1 infection without immunological progression
4. Changes in uptake of antiretroviral therapy and survival in persons with known duration of HIV infection in Europe
5. Regression models and life tables
6. Measures of mortality in the study of individuals infected with the human immunodeficiency virus in the UK haemophilia population
7. Survival after the introduction of HAART in people with known duration of HIV-1 infection